Genpact LTD

Genpact's capital structure is supported by a total equity of $2.55 billion and total liabilities of $3.29 billion, resulting in a debt-to-equity ratio of 0.6, which is below the industry median of 0.8. The company maintains $853.8 million in cash and equivalents, but its net cash position is negative after subtracting total debt of $1.54 billion, indicating a liquidity risk. The current ratio of 1.66 suggests the company has sufficient short-term assets to cover its short-term liabilities, but the risk assessment flags liquidity as medium. Profitability metrics show a return on equity (ROE) of 21.67% and a return on assets (ROA) of 9.46%, both above the industry medians of 18.5% and 7.2%, respectively. The operating margin of 14.77% (calculated from operating income of $750.2 million on revenue of $5.08 billion) is also above the industry median of 12.3%. These figures indicate that Genpact is generating strong returns relative to its peers. The company's revenue is concentrated across three segments: Financial Services, Consumer and Healthcare, and High Tech and Manufacturing. While the input data does not specify exact revenue contributions by segment, the disclosed segments suggest a diversified exposure. The company's geographic exposure is not explicitly detailed in the input data, but the risk assessment highlights dependence on clients in North America and Europe, indicating a moderate concentration risk. Looking ahead, Genpact's revenue is expected to grow by 6.2% in the current fiscal year and 4.8% in the next fiscal year, based on the outlook provided. This growth trajectory is supported by the company's focus on digital transformation and AI integration, which are key drivers in the Business Support Services industry. The capital expenditure of $78.2 million in FY2025 reflects the company's investment in maintaining and expanding its technological infrastructure. The risk assessment highlights a high dilution risk, with the diluted share count at 176.6 million, which is 3.7% higher than the basic share count of 170.3 million. The company's valuation adjustments include a 3.7% dilution adjustment, which is factored into the custom valuations. The risk assessment also notes that the company's net cash is negative after subtracting total debt, which could impact its ability to fund operations without issuing additional shares. Recent filings and transcripts indicate that Genpact is navigating a complex set of risks, including global trade dynamics, cybersecurity threats, and regulatory changes. The company is also investing in new enterprise resource planning systems and expanding its AI capabilities. These developments are expected to influence the company's performance in the coming years, particularly as it seeks to maintain its competitive edge in a rapidly evolving technological landscape.